Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revolution Medicines Inc
(NQ:
RVMD
)
55.09
+1.59 (+2.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revolution Medicines Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 23, 2023
Via
Benzinga
Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90
October 16, 2023
Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday
October 16, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of Revolution Medicines Were Popping on Friday
October 13, 2023
The company released positive phase 1/1b trial data on two cancer therapies.
Via
The Motley Fool
Expert Ratings for Revolution Medicines
October 12, 2023
Via
Benzinga
Stifel Maintains Buy Rating for Revolution Medicines: Here's What You Need To Know
September 21, 2023
Via
Benzinga
Analyst Ratings for Revolution Medicines
August 09, 2023
Via
Benzinga
Why Is Cancer Focused Revolution Medicines Stock Trading Higher Today?
October 13, 2023
Revolution Medicines Inc (NASDAQ: RVMD) released preliminary data for RMC-6236, its RASMULTI(ON) Inhibitor, and RMC-6291, its RASG12C(ON) Inhibitor, from the
Via
Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Quarter
October 06, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID), EQRx, Inc. (Nasdaq - EQRX)
August 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Revolution Medicines Earnings Preview
August 07, 2023
Via
Benzinga
Revolution Medicines Earnings Preview
May 05, 2023
Via
Benzinga
Where Revolution Medicines Stands With Analysts
April 12, 2023
Via
Benzinga
Why Revolution Medicines Stock Is Trading Lower
March 02, 2023
Revolution Medicines Inc (NASDAQ: RVMD) shares are trading lower by 8.77% to $24.18 Thursday morning after the company announced a $300 million offering of common stock.
Via
Benzinga
Top 5 Health Care Stocks That May Crash In Q3
August 07, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
Revolution Medicines Earnings Preview
February 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 01, 2023
Via
Benzinga
Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital
August 01, 2023
Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to
Via
Benzinga
RVMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Revolution Medicines, Inc. Is Fair to Shareholders
August 01, 2023
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 01, 2023
Via
Benzinga
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital
August 01, 2023
From
Revolution Medicines, Inc.; EQRx, Inc.
Via
GlobeNewswire
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is...
Via
Benzinga
$140M Bet On Southwest Gas? Check Out These 4 Stocks Insiders Are Buying
March 13, 2023
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Why Revolution Medicines Shares Are Trading Higher Today
February 28, 2023
Revolution Medicines, Inc. (NASDAQ: RMVD) shares are trading higher after the company reported better-than-expected fourth-quarter results.
Via
Benzinga
Revolution Medicines' Early-Data Validation For Cancer Program Wins Price Target Boost By This Analyst
February 28, 2023
Via
Benzinga
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
February 28, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.